Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

THL Credit, Inc. (TCRD): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?

Page 1 of 2

To the average investor, there are many indicators investors can use to analyze Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top money managers can outpace their index-focused peers by a very impressive margin (see just how much).

THL Credit, Inc. (NASDAQ:TCRD)

Equally as crucial, positive insider trading sentiment is a second way to analyze the marketplace. Obviously, there are lots of reasons for a corporate insider to cut shares of his or her company, but only one, very obvious reason why they would behave bullishly. Plenty of empirical studies have demonstrated the market-beating potential of this method if “monkeys” understand where to look (learn more here).

Now that that’s out of the way, it’s important to study the latest info surrounding THL Credit, Inc. (NASDAQ:TCRD).

How are hedge funds trading THL Credit, Inc. (NASDAQ:TCRD)?

At the end of the second quarter, a total of 10 of the hedge funds we track were long in this stock, a change of 0% from the first quarter. With the smart money’s sentiment swirling, there exists a select group of notable hedge fund managers who were increasing their stakes meaningfully.

When using filings from the hedgies we track, Omega Advisors, managed by Leon Cooperman, holds the biggest position in THL Credit, Inc. (NASDAQ:TCRD). Omega Advisors has a $22.5 million position in the stock, comprising 0.3% of its 13F portfolio. Coming in second is D. E. Shaw of D E Shaw, with a $4.6 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Other peers with similar optimism include Robert B. Gillam’s McKinley Capital Management, John Overdeck and David Siegel’s Two Sigma Advisors and Bruce Silver’s Silver Capital Management LLC.

Since THL Credit, Inc. (NASDAQ:TCRD) has witnessed declining interest from upper-tier hedge fund managers, it’s easy to see that there lies a certain “tier” of money managers that elected to cut their entire stakes heading into Q2. At the top of the heap, Charles Clough’s Clough Capital Partners said goodbye to the largest investment of all the hedgies we track, comprising about $4.1 million in stock, and Bill Miller of Legg Mason Capital Management was right behind this move, as the fund dumped about $0.6 million worth. These moves are important to note, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

Insider trading activity in THL Credit, Inc. (NASDAQ:TCRD)

Bullish insider trading is particularly usable when the company we’re looking at has seen transactions within the past six months. Over the latest half-year time frame, THL Credit, Inc. (NASDAQ:TCRD) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to THL Credit, Inc. (NASDAQ:TCRD). These stocks are Capital Southwest Corporation (NASDAQ:CSWC), Westwood Holdings Group, Inc. (NYSE:WHG), Pzena Investment Management, Inc. (NYSE:PZN), PennantPark Investment Corp. (NASDAQ:PNNT), and Noah Holdings Limited (ADR) (NYSE:NOAH). All of these stocks are in the asset management industry and their market caps are similar to TCRD’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!